EG ·
AMIKIN 500mg 1/VIAL
AMIKIN 500mg 1/VIAL
Composition
These source-reported data require scientific review and are not treatment advice.
AMIKACIN
500.00000 MG · AMOUNT_PER_UNIT
Registration
Packages and prices
VIAL
Explainable alternatives
Candidates are informational and are not automatic authorization for substitution or dispensing.
| Product | Match | Differences | Price |
|---|---|---|---|
| AMIKACIN 100MG/2ML 1/VIAL | SAME_ACTIVE_INGREDIENT_SET | strength_or_basis | — EGP |
| AMIKACIN 500MG/2ML 1/VIAL | SAME_ACTIVE_INGREDIENT_SET | strength_or_basis | — EGP |
| AMIKIN 100 mg 1/VIAL | SAME_ACTIVE_INGREDIENT_SET | strength_or_basis | — EGP |
| LIKACIN 500MG- VIALS | SAME_ACTIVE_INGREDIENT_SET | strength_or_basis | — EGP |
| AMIKACIN 100ML LOTION-SPRAY | SAME_ACTIVE_INGREDIENT_SET | strength_or_basis, dosage_form | — EGP |
| AMIKACIN 50ML LOTION-SPRAY | SAME_ACTIVE_INGREDIENT_SET | strength_or_basis, dosage_form | — EGP |
| VETOMIKACIN 100 MG/2 ML 1 VIAL | SAME_ACTIVE_INGREDIENT_SET | strength_or_basis, route | — EGP |
| VETOMIKACIN 500 MG/2 ML 1 VIAL | SAME_ACTIVE_INGREDIENT_SET | strength_or_basis, route | — EGP |
| AMIKIN 250MG/2ML 1/VIAL | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, route | — EGP |
| ADVOMIKACIN 500 MG/2ml VIAL | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, route | — EGP |